반응식
[CH2:1]([O:3]C1C=CC2C(=CC=CC=2)N1C(OCC)=O)[CH3:2].C(O)(=O)C.[NH:23]([C:25]([C:27]1[C:28]([N:36]2[CH2:41][CH2:40][N:39]([C:42]([O:44][C:45]([CH3:48])([CH3:47])[CH3:46])=[O:43])[CH2:38][CH2:37]2)=[C:29]2[CH:35]=[CH:34][NH:33][C:30]2=[N:31][CH:32]=1)=[O:26])[NH2:24]>C1COCC1.C(#N)C>[C:1]([NH:24][NH:23][C:25]([C:27]1[C:28]([N:36]2[CH2:41][CH2:40][N:39]([C:42]([O:44][C:45]([CH3:48])([CH3:47])[CH3:46])=[O:43])[CH2:38][CH2:37]2)=[C:29]2[CH:35]=[CH:34][NH:33][C:30]2=[N:31][CH:32]=1)=[O:26])(=[O:3])[CH3:2]참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
Ethyl 2-ethoxyquinoline-1(2H)-carboxylate (226 mg, 0.916 mmol) was added to acetic acid (50.0 mg, 0.832 mmol) in THF/ACN (5 mL), and the reaction was stirred at room temperature for 1 hour. tert-Butyl 4-(5-(hydrazinecarbonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate (300 mg, 0.832 mmol, Example 18) was added, and the reaction was heated to 70° C. for 1 hour. The reaction was then concentrated to dryness. The resulting residue was crystallized from DCM to yield tert-butyl 4-(5-(2-acetylhydrazinecarbonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate (241 mg, 71.9% yield) as a solid.
후처리
- temperaturethe reaction was heated to 70° C. for 1 hour
- concentrationThe reaction was then concentrated to dryness
- customThe resulting residue was crystallized from DCM
출처 및 근거
- ORD 기록
- ord-7131c0df112d4b0aa02df20b00ba3200
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08841304B2
연결된 노트
불러오는 중…